Terms: = Colorectal cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Staging
30 results:
1. A novel lncRNA associated with the prognosis of patients with colorectal cancer resists apoptosis through the LYN/bcl-2 pathway.
An G; Hui J; Zhang W; Fan A; Zhou Y; Zhao X; Lu Y; Wang X
Biochem Biophys Res Commun; 2024 Sep; 723():150177. PubMed ID: 38810320
[TBL] [Abstract] [Full Text] [Related]
2. Fluorescence-based sentinel lymph node mapping and lymphography evaluation: results from the IHU-IRCAD-EAES EURO-FIGS registry.
Picchetto A; Cinelli L; Bannone E; Baiocchi GL; Morales-Conde S; Casali L; Spinoglio G; Franzini C; Santi C; D'Ambrosio G; Copaescu C; Rollo A; Balla A; Lepiane P; Paganini AM; Detullio P; Quaresima S; Pesce A; Luciano T; Bianchi G; Marescaux J; Diana M
Surg Endosc; 2023 Jul; 37(7):5472-5481. PubMed ID: 37043006
[TBL] [Abstract] [Full Text] [Related]
3. [Expression and clinicopathological significance of
Yang XG; Yang JW; Zhao PJ; Cheng W; Shi HB; Zhang B; Fu QC; Li Y
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Apr; 33(2):148-153. PubMed ID: 34008361
[TBL] [Abstract] [Full Text] [Related]
4. Primary intestinal follicular lymphoma presenting as multiple lymphomatous polyposis.
Ng HJ; Schmigylski R; Nale K; Collins P
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33318279
[TBL] [Abstract] [Full Text] [Related]
5. Association of single nucleotide polymorphisms in the coding region of bcl-2 with the occurrence and prognosis of colorectal cancer: A case-control study.
Huang B; Liu X; Sun C; Wang L; Yang L
Cancer Biomark; 2017; 18(4):433-439. PubMed ID: 28106544
[TBL] [Abstract] [Full Text] [Related]
6. Deregulation of miR-126 expression in colorectal cancer pathogenesis and its clinical significance.
Ebrahimi F; Gopalan V; Wahab R; Lu CT; Smith RA; Lam AK
Exp Cell Res; 2015 Dec; 339(2):333-41. PubMed ID: 26455548
[TBL] [Abstract] [Full Text] [Related]
7. B-cell lymphoma 2 and β-catenin expression in colorectal cancer and their prognostic role following surgery.
Balzi M; Ringressi MN; Faraoni P; Booth C; Taddei A; Boni L; Bechi P
Mol Med Rep; 2015 Jul; 12(1):553-60. PubMed ID: 25738398
[TBL] [Abstract] [Full Text] [Related]
8. Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?
Hur H; Kim NK; Min BS; Baik SH; Lee KY; Koom WS; Ahn JB; Kim H
Dis Colon Rectum; 2014 May; 57(5):592-601. PubMed ID: 24819099
[TBL] [Abstract] [Full Text] [Related]
9. Bag-3 expression is involved in pathogenesis and progression of colorectal carcinomas.
Yang X; Tian Z; Gou WF; Takahashi H; Yu M; Xing YN; Takano Y; Zheng HC
Histol Histopathol; 2013 Sep; 28(9):1147-56. PubMed ID: 23553442
[TBL] [Abstract] [Full Text] [Related]
10. The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.
Peddaboina C; Jupiter D; Fletcher S; Yap JL; Rai A; Tobin RP; Jiang W; Rascoe P; Rogers MK; Smythe WR; Cao X
BMC Cancer; 2012 Nov; 12():541. PubMed ID: 23171055
[TBL] [Abstract] [Full Text] [Related]
11. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
[TBL] [Abstract] [Full Text] [Related]
12. [Mechanism of polycomb Bmi1-targeted therapy for colorectal cancer].
Zhang H; Ye YJ; Cui ZR; Wang S
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):623-6. PubMed ID: 21866458
[TBL] [Abstract] [Full Text] [Related]
13. [Rectal non-Hodgkin lymphoma with concomitant rectal adenocarcinoma: a case report and literature review].
Song W; He YL; Han FH; Cai SR; Peng JJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):617-9. PubMed ID: 21866456
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
[TBL] [Abstract] [Full Text] [Related]
15. Factors influencing prognosis after neo-adjuvant chemoradiation therapy for rectal carcinoma.
Moral M; Fdez-Aceñero MJ; Cuberes R; Suárez A
Acta Chir Belg; 2009; 109(3):345-51. PubMed ID: 19943591
[TBL] [Abstract] [Full Text] [Related]
16. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract] [Full Text] [Related]
17. Potential role of bcl-2 expression and apoptotic body index in colorectal cancer.
El-Awady S; Morshed M; El-Shobaky M; Abo-Hashem M; Ghazy H
Hepatogastroenterology; 2008; 55(81):76-81. PubMed ID: 18507083
[TBL] [Abstract] [Full Text] [Related]
18. Growth associated proteins in tumor cells and stroma related to disease progression of colon cancer accounting for tumor tissue PGE2 content.
Cahlin C; Lönnroth C; Arvidsson A; Nordgren S; Lundholm K
Int J Oncol; 2008 Apr; 32(4):909-18. PubMed ID: 18360718
[TBL] [Abstract] [Full Text] [Related]
19. Can the clinical outcome in stage II colon carcinomas be predicted by determination of molecular marker expression?
Fernández-Cebrián JM; Nevado Santos M; Vorwald Kuborn P; Pardo de Lama M; Martín-Cavanna J; Pacheco Martínez P; Fernández Escudero B; Ramos Fernández M
Clin Transl Oncol; 2007 Oct; 9(10):663-70. PubMed ID: 17974527
[TBL] [Abstract] [Full Text] [Related]
20. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
Gurzu S; Jung J; Mezei T; Pávai Z
Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794
[TBL] [Abstract] [Full Text] [Related]
[Next]
